Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ashland

46.53
-2.2000-4.51%
Pre-market: 46.580.0500+0.11%04:32 EDT
Volume:745.08K
Turnover:35.10M
Market Cap:2.20B
PE:-101.47
High:50.83
Open:50.83
Low:45.79
Close:48.73
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
More
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h

Beam Therapeutics to Encore Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at 2025 Tandem Meetings of ASTCT and CIBMTR

GlobeNewswire
·
23 Jan

Ashland Keeps Dividend at $0.405 per Share, Payable March 15 to Shareholders of Record on March 1

MT Newswires Live
·
21 Jan

Press Release: Ashland board authorizes quarterly dividend

Dow Jones
·
20 Jan

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

GlobeNewswire
·
16 Jan

Bear of the Day: Ashland Inc (ASH)

Zacks
·
16 Jan

International Paper and Ashland have been highlighted as Zacks Bull and Bear of the Day

Zacks
·
16 Jan

Here's Why Shareholders May Want To Be Cautious With Increasing Ashland Inc.'s (NYSE:ASH) CEO Pay Packet

Simply Wall St.
·
14 Jan

Former C.H. Robinson exec joins Armada Sunset to lead strategic growth

FreightWaves
·
14 Jan

C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology

GlobeNewswire
·
14 Jan

Ashland sets date for first-quarter fiscal 2025 earnings release and conference call webcast

GlobeNewswire
·
14 Jan

Press Release: Rigel Provides Business Update and 2025 Outlook

Dow Jones
·
13 Jan

Press Release: Beam Therapeutics Announces Progress in Hematology and Genetic Disease Franchises and Outlines Key 2025 Anticipated Catalysts

Dow Jones
·
13 Jan

UBS Trims Price Target on Ashland to $95 From $96, Keeps Buy Rating

MT Newswires Live
·
10 Jan

SELLAS Announces Key Business Objectives for 2025

GlobeNewswire
·
08 Jan

Returns At Ashland (NYSE:ASH) Are On The Way Up

Simply Wall St.
·
08 Jan

New Strong Sell Stocks for January 7th

Zacks
·
07 Jan

U.S. RESEARCH ROUNDUP-Citigroup, Fortinet, Kenvue

Reuters
·
06 Jan

Argus Research Sticks to Their Buy Rating for Ashland (ASH)

TIPRANKS
·
03 Jan

Ashland Inks Deal to Sell Avoca Business to Optimize Portfolio

Zacks
·
30 Dec 2024

Press Release: Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech

Dow Jones
·
27 Dec 2024

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."